Vicki L. Goodman
EVP, Prod Dev & Med Aff &CMO, Exelixis.
Companies
- Mural Oncology plcChief Medical Officer Nov 15, 2023 to now1
- ExelixisEVP, Prod Dev & Med Aff &CMO Jan 6, 2022 to Apr 5, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Exelixis EXEL307,654 shares3$19.3M at $62.59Apr 3, 2023- Mural Oncology plc0 shares4Dec 5, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 5, 2025Returned to company 84,727 shares of Mural Oncology plc4
- Nov 10, 2025Sold 5,036 shares at $2.08 of Mural Oncology plc5
- Mar 3, 2025Granted 35,000 shares of Mural Oncology plc6
- Feb 24, 2025Sold 13,186 shares at $3.89 of Mural Oncology plc7
- Nov 7, 2024Sold 5,069 shares at $3.33 of Mural Oncology plc8
- Dec 14, 2023Granted 73,018 shares of Mural Oncology plc9
- Apr 3, 2023Granted 82,566 shares of Exelixis3
- Feb 15, 2023Shares withheld for tax 17,299 shares at $18.08 of Exelixis10
- Jan 4, 2022Shares withheld for tax 7,613 shares at $19.18 of Exelixis11
- Jan 4, 2022Granted 250,000 shares of Exelixis11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Nov 10, 2025
- 6SEC EDGARForm 4 filed Mar 5, 2025
- 7SEC EDGARForm 4 filed Feb 25, 2025
- 8SEC EDGARForm 4 filed Nov 8, 2024
- 9SEC EDGARForm 4 filed Dec 18, 2023
- 10SEC EDGARForm 4 filed Feb 17, 2023
- 11SEC EDGARForm 4 filed Jan 6, 2022